| Bioactivity | SPPHPSPAFSPAFDNLYYWDQ TFA is a multi-epitope class II rat HER2/neu peptide. SPPHPSPAFSPAFDNLYYWDQ TFA can be used for the research class II HER2-DC1 vaccine studies[1]. |
| Name | SPPHPSPAFSPAFDNLYYWDQ TFA |
| Sequence | Ser-Pro-Pro-His-Pro-Ser-Pro-Ala-Phe-Ser-Pro-Ala-Phe-Asp-Asn-Leu-Tyr-Tyr-Trp-Asp-Gln |
| Shortening | SPPHPSPAFSPAFDNLYYWDQ |
| Formula | C116H150N26O33.xC2HF3O2 |
| Molar Mass | 2436.59 (free acid) |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Kodumudi KN, et, al. Sequential Anti-PD1 Therapy Following Dendritic Cell Vaccination Improves Survival in a HER2 Mammary Carcinoma Model and Identifies a Critical Role for CD4 T Cells in Mediating the Response. Front Immunol. 2019 Aug 14;10:1939. |
SPPHPSPAFSPAFDNLYYWDQ TFA
CAS: F: C116H150N26O33.xC2HF3O2 W: 2436.59 (free acid)
SPPHPSPAFSPAFDNLYYWDQ TFA is a multi-epitope class II rat HER2/neu peptide. SPPHPSPAFSPAFDNLYYWDQ TFA can be used for th
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.